Kidney Compass: Navigating Clinical Trials

About Kidney Compass: Navigating Clinical Trials

Hosted by Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, Kidney Compass: Navigating Clinical Trials is a regular podcast exploring and breaking down the latest updates and nuances of clinical trials in nephrology. By listening to Kidney Compass, you'll get the guidance you need to navigate the changing landscape of clinical trials across the spectrum of kidney disease.

Publisher

Kidney Compass: Navigating Clinical Trials

Category

health & fitness

Language

en

Explicit

No

First episode

21 Oct 2024

Latest episode

11 Sept 2026

Latest episodes

23 episodes in the feed.

1. 

   11 Sept 2026

   FIND-CKD Extends Finerenone's Benefit to Non-Diabetic CKD

   In a special episode of Kidney Compass, Shikha Wadhwani, MD, MS, puts her regular co-host, Brendan Neuen, MBBS, PhD, in the "hot seat," asking him about results from FIND-CKD, the phase 3 trial showing finerenone slows eGFR decline and cuts cardiorenal risk by 23% in non-diabetic chronic kidney disease (CKD) over 32 months of follow-up, including the prespecified glomerulonephritis (GN) subgroup analysis he presented at the European Renal Association (ERA) Congress in June. For more: https://www.hcplive.com/view/kidney-compass-find-ckd-extends-finerenone-s-benefit-to-non-diabetic-ckd (https://www.hcplive.com/view/kidney-compass-find-ckd-extends-finerenone-s-benefit-to-non-diabetic-ckd)

2. 

   17 Aug 2026

   Rituximab Cuts Relapse Risk in MCD, FSGS in TURING Trial

   At the European Renal Association (ERA) Congress in Glasgow, Scotland, results from the TURING trial offered long-awaited evidence that rituximab can meaningfully reduce relapse rates in adults with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS). These conditions have been historically managed with prolonged, high-dose corticosteroid courses, carrying a substantial burden of adverse effects. In this episode of Kidney Compass, host Brendon Neuen, MBBS, PhD, spoke with Lisa Willcocks, MBBChir, MRCP, PhD, a consultant nephrologist who leads the primary glomerular disease service at Addenbrooke's Hospital in Cambridge, United Kingdom, about the trial she presented as a late-breaking clinical result at the congress. Read more: https://www.hcplive.com/view/kidney-compass-turing-trial-rituximab-relapse-risk-mcd-fsgs (https://www.hcplive.com/view/kidney-compass-turing-trial-rituximab-relapse-risk-mcd-fsgs)

3. 

   14 Aug 2026

   VISIONARY 2-Year eGFR Data in IgA Nephropathy

   Hosts Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, welcome Dana Rizk, MD, professor of medicine in the Division of Nephrology at the University of Alabama at Birmingham. Rizk walks through the 24-month eGFR and safety findings from the phase 3 VISIONARY trial of sibeprenlimab (Voyxact) in IgA nephropathy (IgAN) in the lastest episode of Kidney Compass.

Who has been a guest on Kidney Compass: Navigating Clinical Trials

Names identified in recent episode analyses. Showing up to five guests.

• Chee Kay Cheung
• Vlado Perkovic
• Rajiv Agarwal
• Laura Mariani
• Daniel Gale

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

3 ratings

Spotify

5.0 / 5

7 ratings

Podcast Authority Score: 23 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

33

Social presence

0

YouTube

0

Engagement

32

Contact Kidney Compass: Navigating Clinical Trials

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Freely Filtered, a NephJC Podcast

• 

  GN in Ten

• 

  Harrison's PodClass: Internal Medicine Cases and Board Prep

• 

  The Curbsiders Internal Medicine Podcast

• 

  A pinch of salt - A podcast by ERA

• 

  The Clinical Problem Solvers

Questions about Kidney Compass: Navigating Clinical Trials